DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC.

Autor: Liu, Nanbin1,2,3 (AUTHOR) lnb509755573@stu.xjtu.edu.cn, Zhang, Hailong1,2,3 (AUTHOR) long753852@stu.xjtu.edu.cn, Zhang, Chunli1,3 (AUTHOR) chunlizhang@xjtu.edu.cn, Li, Zeyu1,2,3 (AUTHOR) lzy2152@stu.xjtu.edu.cn, Huang, Limin1,3 (AUTHOR) huanglimin@stu.xjtu.edu.cn, Sun, Jin1,2,3 (AUTHOR) jinsun2014@xjtu.edu.cn, Qi, Junan2,4 (AUTHOR), Deng, Xi1,2,3 (AUTHOR) d605365632@stu.xjtu.edu.cn, Huang, Na1,2,3 (AUTHOR) huangna123@xjtu.edu.cn, Mu, Yanhua1,2,3 (AUTHOR) muyanhua@xjtu.edu.cn, Li, Zongfang1,2,3 (AUTHOR) lzf2568@mail.xjtu.edu.cn, Tian, Hongwei1,2,3 (AUTHOR) lzf2568@mail.xjtu.edu.cn
Zdroj: Cancers. Nov2023, Vol. 15 Issue 21, p5228. 23p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje